%0 Journal Article %A Gail M. Thornton %A Brian A Fleck %A Dhyey Dandnayak %A Emily Kroeker %A Lexuan Zhong %A Lisa Hartling %T The impact of heating, ventilation and air conditioning (HVAC) design features on the transmission of viruses, including the 2019 novel coronavirus (COVID-19): a systematic review of humidity %D 2021 %R 10.1101/2021.11.05.21265995 %J medRxiv %P 2021.11.05.21265995 %X The aerosol route has been a pathway for transmission of many viruses. Similarly, recent evidence has determined aerosol transmission for SARS-CoV-2 to be significant. Consequently, public health officials and professionals have sought data regarding the role of Heating, Ventilation, and Air Conditioning (HVAC) features as a means to mitigate transmission of viruses, particularly coronaviruses. Using international standards, a systematic review was conducted to comprehensively identify and synthesize research examining the effect of humidity on transmission of coronaviruses and influenza. The results from 24 relevant studies showed that: increasing from mid (40-60%) to high (>60%) relative humidity (RH) for SARS-CoV-2 was associated with decreased virus survival; although SARS-CoV-2 results appear consistent, coronaviruses do not all behave the same; increasing from low (<40%) to mid RH for influenza was associated with decreased persistence, infectivity, viability, and survival, however effects of increased humidity from mid to high for influenza were not consistent; and medium, temperature, and exposure time were associated with inconsistency in results for both coronaviruses and influenza. Adapting HVAC humidity to mitigate virus transmission is a complex approach due to difficulties of humidity control; humidity is a feature to be considered in conjunction with other HVAC features.Practical Implications While increasing relative humidity from mid (40-60%RH) to high (>60%RH) was associated with decreased SARS-CoV-2 survival, coronaviruses did not all behave the same way. As a result, blanket prescriptive humidity levels for coronavirus mitigation are difficult to ascertain. While influenza survival varied from mid to high RH, increased humidity from low (<40%RH) to mid (40-60%RH) RH was associated with decreased virus survival with maximum survival at low RH. When controlling humidity as an HVAC feature, practitioners should take into account virus type and temperature. Future research should also consider the impact of exposure time, temperature, and medium when designing experiments, while also working towards more standardized testing procedures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is funded by a Canadian Institutes of Health Research (CIHR) Operating Grant: Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity [https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=422567&lang=en]. Dr. Hartling is supported by a Canada Research Chair in Knowledge Synthesis and Translation. Drs. Fleck and Zhong are supported by the NSERC Discovery program.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Systematic Review of publicly available literature.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data come from analysis of publicly available literature. %U https://www.medrxiv.org/content/medrxiv/early/2021/11/08/2021.11.05.21265995.full.pdf